Sufficient earnings growth to continually increase dividends at a comfortably low payout ratio that also accommodates expansion capex is an excellent signal for strong upside potential.
Dividend Aristocrats are outperforming SPY in July but still trail year-to-date; select Aristocrats delivered double-digit gains and strong dividend growth. 47 of 69 Aristocrats raised dividends in 2025, with an average growth rate of 4.92% and more increases expected, signaling ongoing income reliability. My 'Promising Aristocrats' list, focused on undervaluation and projected total return, has outperformed both NOBL and SPY since late June.
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
![]() ABT 2 weeks ago Announced | Quarterly | $0.59 Per Share |
![]() ABT 3 months ago Paid | Quarterly | $0.59 Per Share |
![]() ABT 6 months ago Paid | Quarterly | $0.59 Per Share |
![]() ABT 9 months ago Paid | Quarterly | $0.55 Per Share |
![]() ABT 15 Jul 2024 Paid | Quarterly | $0.55 Per Share |
15 Oct 2025 (In 2 months) Date | | 1.3 Cons. EPS | - EPS |
14 Oct 2025 (In 2 months) Date | | 1.34 Cons. EPS | - EPS |
17 Jul 2025 Date | | 0.99 Cons. EPS | 1.01 EPS |
16 Jul 2025 Date | | 1.25 Cons. EPS | - EPS |
15 Apr 2025 Date | | - Cons. EPS | - EPS |
![]() ABT 2 weeks ago Announced | Quarterly | $0.59 Per Share |
![]() ABT 3 months ago Paid | Quarterly | $0.59 Per Share |
![]() ABT 6 months ago Paid | Quarterly | $0.59 Per Share |
![]() ABT 9 months ago Paid | Quarterly | $0.55 Per Share |
![]() ABT 15 Jul 2024 Paid | Quarterly | $0.55 Per Share |
15 Oct 2025 (In 2 months) Date | | 1.3 Cons. EPS | - EPS |
14 Oct 2025 (In 2 months) Date | | 1.34 Cons. EPS | - EPS |
17 Jul 2025 Date | | 0.99 Cons. EPS | 1.01 EPS |
16 Jul 2025 Date | | 1.25 Cons. EPS | - EPS |
15 Apr 2025 Date | | - Cons. EPS | - EPS |
Medical - Devices Industry | Healthcare Sector | Robert B. Ford CEO | XMIL Exchange | US0028241000 ISIN |
US Country | 114,000 Employees | 15 Jul 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains: